Farah P. serves as the Director at Boston Strategic Partners, where she leverages her extensive expertise in Health Economics and Outcomes Research (HEOR) to drive impactful studies that address critical healthcare disparities and enhance patient outcomes. With a Ph.D. in Pharmaceutical Health Services Outcomes and...
Farah P. serves as the Director at Boston Strategic Partners, where she leverages her extensive expertise in Health Economics and Outcomes Research (HEOR) to drive impactful studies that address critical healthcare disparities and enhance patient outcomes. With a Ph.D. in Pharmaceutical Health Services Outcomes and Policy, Farah has established herself as a thought leader in the field, particularly in the realm of observational and real-world evidence studies. Her current role involves leading high-stakes projects that not only generate valuable insights but also inform strategic decision-making for healthcare stakeholders.
One of her notable projects includes an observational study that delves into health equity, specifically analyzing the outcomes associated with the administration of a plasma product in patients undergoing cardiac surgery. This study aims to uncover disparities in treatment efficacy and patient experiences, ultimately contributing to more equitable healthcare practices. Additionally, Farah spearheaded the design and execution of a pivotal study focused on survival-based outcomes for an ovarian cancer therapy. This project is instrumental in generating real-world evidence that supports key value messaging, ensuring that the therapy is positioned effectively within the competitive oncology landscape.
Farah's proficiency in statistical techniques, particularly in survival analysis and data collection, complements her strong writing skills, enabling her to communicate complex findings clearly and effectively. Her ability to design comprehensive surveys and engage in intercultural communication further enhances her capability to navigate the multifaceted healthcare industry. As she continues to champion initiatives that prioritize health promotion and economic outcomes, Farah remains dedicated to advancing the field of HEOR and improving patient care on a broader scale.
